NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,085 | +38.0% | 7,042 | +92.6% | 0.00% | – |
Q2 2023 | $6,583 | +31247.6% | 3,657 | -74.1% | 0.00% | -100.0% |
Q1 2023 | $21 | -30.0% | 14,100 | -33.3% | 0.00% | 0.0% |
Q4 2022 | $30 | -99.9% | 21,129 | +29.0% | 0.00% | 0.0% |
Q3 2022 | $45,000 | +18.4% | 16,375 | +100.5% | 0.00% | 0.0% |
Q2 2022 | $38,000 | -57.8% | 8,169 | -55.8% | 0.00% | 0.0% |
Q1 2022 | $90,000 | +350.0% | 18,465 | +443.1% | 0.00% | – |
Q4 2021 | $20,000 | -35.5% | 3,400 | -24.9% | 0.00% | -100.0% |
Q3 2021 | $31,000 | +47.6% | 4,525 | +75.7% | 0.00% | 0.0% |
Q2 2021 | $21,000 | 0.0% | 2,575 | +23.3% | 0.00% | – |
Q1 2021 | $21,000 | -67.7% | 2,089 | -64.8% | 0.00% | -100.0% |
Q4 2020 | $65,000 | -56.4% | 5,931 | -65.1% | 0.00% | 0.0% |
Q3 2020 | $149,000 | +198.0% | 16,970 | +624.6% | 0.00% | 0.0% |
Q2 2020 | $50,000 | +284.6% | 2,342 | +563.5% | 0.00% | +100.0% |
Q1 2020 | $13,000 | +116.7% | 353 | +256.6% | 0.00% | – |
Q4 2019 | $6,000 | -50.0% | 99 | -74.0% | 0.00% | -100.0% |
Q3 2019 | $12,000 | -87.5% | 381 | -94.0% | 0.00% | -83.3% |
Q2 2019 | $96,000 | – | 6,376 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |